| |JULY 20269NEW STRATEGIC PACT POWERS NEXT-GEN AI LED DRUG DISCOVERYINDIA SEES RISE IN DIFFERENTIATED PRODUCTS WITH NEW DRUG ENTRYWILL ANTIBIOTIC RESISTANCE CRISIS PUSH PUBLIC AWARENESS?INDIA'S BREAST CANCER SURVIVAL RATE CLIMBS, BUT RISKS REMAINArtificial intelligence is rapidly transforming the Indian pharmaceutical landscape, enabling faster, more accurate, and cost-efficient drug development processes. As companies seek to stay competitive in a global innovation race, AI-integrated platforms are emerging as critical tools in identifying novel drug targets and accelerating clinical success. AI-led drug discovery is now gaining traction in India, supported by strategic collaborations that combine computational power with biological expertise. These partnerships are helping to reduce traditional difficulties in drug development while improving precision, ultimately reshaping how therapies are discovered, designed, and delivered across the pharmaceutical value chain. PODifferentiated products in India are gaining strong momentum as pharmaceutical companies are increasingly focusing on innovation-led drug development to meet medical needs. The latest anti-inflammatory drug launch in India reflects a broader shift toward research-driven, value-added therapies rather than conventional generics.With the emergence of new risks in routine and complex surgical procedures, the threat of antibiotic resistance is increasingly attracting public awareness, especially in healthcare systems around the world. Today, experts are concerned that the power of antibiotics, which long ago seemed to be the backbone of modern medicine, is becoming increasingly ineffective, and that even simple surgeries can be life-threatening.This crisis underscores why public awareness is no longer optional but essential in addressing one of the most crucial global health challenges. As infections become harder to treat, the need for coordinated global action and informed public behavior is becoming more urgent than ever. POIndia's Breast Cancer Survival Rate is improving, offering hope to thousands of women. However, the country still trails many high-income nations. A new World Health Organization (WHO) report shows that India's five-year survival rate has reached 66 percent . While this marks steady progress, many women still miss the chance of early treatment.Breast cancer remains the most common cancer among women in India. Experts say timely diagnosis and better access to treatment can save many more lives. The WHO report compared survival rates across countries. It found that women in wealthy nations have much better outcomes. Their five-year survival rates often cross 85 percent . The report says this gap is mainly due to early diagnosis, regular screening, and better healthcare access. POEbola protection. Scientists hope the vaccine will help countries respond faster to future outbreaks. The study marks an important step in global health research.The vaccine, called ChAdOx1 BDBV, is the first designed specifically for the Bundibugyo strain. Existing Ebola vaccines mainly target the Zaire strain. They do not have approval for Bundibugyo Ebola. This makes the new vaccine an important addition to Ebola research and outbreak response. POThis trend highlights how companies are leveraging strategic collaborations, advanced formulations, and targeted delivery mechanisms to create clinically superior products. As competition intensifies in the Indian pharmaceutical market, differentiated developments are emerging as a key driver in enabling firms to stand out while improving patient outcomes. PO
< Page 8 | Page 10 >